Abstract
Background. Cervical cancer is one of the most preventable malignancies in females. However, there is an increasing trend of disease incidence mainly due to the low specificity of routine screening tests.
Aim. To assess the diagnostic value of standard tests for the diagnosis of cervix disorders based on the Digene test.
Materials and methods. The obtained data were processed using the Statistica software package. Due to the unique features of specimens obtained, non-parametric methods were used for small samples with extreme data variability and possible artifacts. These methods do not require an assumption of "normality" of distribution. KruskalWallis rank analysis of variance and MannWhitney test for comparison of individual samples were used to estimate the relationship between the studied parameter and controlled factors. Median (Me) and quartiles (Q1 and Q3) were used in describing the results.
Results. The study found a low performance of colposcopy and cytology and a higher performance of status assessment for human papillomavirus.
Conclusion. Our findings indicate that viral load measurement is only sometimes informative. This test can be used as a stage 2 screening; additional data are needed for further patient management. Digene test helps to determine the risk group for a follow-up study.
Subject
Obstetrics and Gynecology
Reference28 articles.
1. Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021 [Zlokachestvennye novoobrazovaniia v Rossii v 2020 godu (zabolevaemost' i smertnost'). Pod red. AD Kaprina, VV Starinskogo, AO Shakhzadovoi. Moscow: MNIOI im. P.A. Gertsena − filial FGBU «NMITs radiologii» Minzdrava Rossii, 2021 (in Russian)].
2. Dalstein V, Bory J, Graesslin O, et al. Human papillomavirus testing for primary cervical cancer screening. Basel: Karger, 2006.
3. Overview of the European and North American studies on HPV testing in primary cervical cancer screening
4. Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
5. Доброкачественные и предраковые заболевания шейки матки с позиции профилактики рака. Клинические рекомендации (протоколы диагностики и ведения больных). РОАГ. Утв. МЗ РФ от 02.11.2017. №15-4/10/2/-76-76. М., 2017 [Dobrokachestvennye i predrakovye zabolevaniia sheiki matki s pozitsii profilaktiki raka. Klinicheskie rekomendatsii (protokoly diagnostiki i vedeniia bol'nykh). ROAG. Utv. MZ RF ot 02.11.2017. №15-4/10/2/-76-76. Moscow, 2017 (in Russian)].